At the Desert Liver Meeting 2025, Yukti Choudhury, Director of Clinical Development at HistoIndex, delivered an insightful presentation titled “Beyond Conventional Fibrosis Staging: Next-Generation Histology for Precise and Quantitative Fibrosis Assessment.”

Her talk unveiled HistoIndex’s vision for advancing MASH clinical care with next-generation digital pathology solutions—starting with FibroSIGHT™, our first Laboratory Developed Test (LDT) for semi-autonomous fibrosis assessment.